Local government intervention slows pharm-emerging economies

05/2/2011 | PharmExec.com

In Turkey and other emerging pharmaceutical markets, governments are taking steps to bolster domestic production, such as by subjecting foreign-made drugs to separate certification inspections that slow the flow of imports, Pharmaceutical Executive magazine editor-in-chief William Looney writes. The average time for a new drug to get marketing approval in Turkey is 772 days, compared with about 200 days in the European Union, according to a trade association.

View Full Article in:

PharmExec.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC